Curaleaf (OTCMKTS:CURLF) Downgraded by Zacks Research to “Hold”

Curaleaf (OTCMKTS:CURLF) was downgraded by research analysts at Zacks Research from a “strong-buy” rating to a “hold” rating in a report issued on Tuesday, Zacks reports.

CURLF has been the topic of a number of other reports. Citigroup reiterated a “buy” rating on shares of Curaleaf in a report on Thursday, August 6th. UBS Group set a $6.00 target price on shares of Curaleaf in a report on Monday, October 5th. One investment analyst has rated the stock with a Strong Buy rating, two have issued a Buy rating and one has assigned a Hold rating to the company’s stock. According to MarketBeat.com, Curaleaf has an average rating of “Buy” and a consensus target price of $6.00.

Curaleaf Stock Down 2.9%

CURLF stock opened at $8.56 on Tuesday. The company has a debt-to-equity ratio of 1.06, a current ratio of 1.52 and a quick ratio of 0.73. The stock has a market capitalization of $2.00 billion, a P/E ratio of -65.84 and a beta of 1.55. The business has a 50-day moving average of $9.91 and a 200-day moving average of $8.68. Curaleaf has a fifty-two week low of $5.40 and a fifty-two week high of $15.15.

Curaleaf (OTCMKTS:CURLF) last announced its earnings results on Wednesday, August 5th. The company reported $0.05 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.20) by $0.25. Curaleaf had a negative return on equity of 0.88% and a negative net margin of 2.62%. The business had revenue of $340.10 million for the quarter, compared to analyst estimates of $332.00 million. On average, sell-side analysts anticipate that Curaleaf will post 0.01 earnings per share for the current fiscal year.

About Curaleaf

Curaleaf Holdings, Inc is a cannabis company that cultivates, processes, manufactures and sells cannabis products. Through its retail dispensaries and wholesale operations, the company offers flower, pre-rolls, vaporizers, edibles, concentrates, tinctures and other cannabis-derived products for medical and adult-use markets, where permitted by law.

Curaleaf markets products under brands that include Curaleaf, Select and Grassroots. Its business is primarily focused on the United States, where it operates a network of cultivation and processing facilities, dispensaries and distribution operations across multiple state-regulated cannabis markets.